Similar Papers

Paper Title
Journal
Date
Author
A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
...
Blood | VOL. 130
, et. al. ...
25 Jun 2021
Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality
Gautam Borthakur ... Jorge E Cortes
Blood | VOL. 130
Gautam Borthakur, et. al.Gautam Borthakur ... Jorge E Cortes
07 Dec 2017
The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial
Mahesh Swaminathan ... Jorge E Cortes
Blood | VOL. 130
Mahesh Swaminathan, et. al.Mahesh Swaminathan ... Jorge E Cortes
07 Dec 2017
Impact of Cytogenetic Abnormalities (CA) on Outcome of Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab: Results from a Phase 2 Study
Hind Rafei ...
Blood | VOL. 136
Hind Rafei, et. al.Hind Rafei ...
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface.
Zohreh Mansoori Moghadam ... Philipp Henneke
Blood | VOL. -
Zohreh Mansoori Moghadam, et. al.Zohreh Mansoori Moghadam ... Philipp Henneke
03 Feb 2025
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.
Michael C Zaiken ... Bruce R Blazar
Blood | VOL. -
Michael C Zaiken, et. al.Michael C Zaiken ... Bruce R Blazar
03 Feb 2025
How I approach pharmacological thromboprophylaxis in children.
Anthony A Sochet ... Neil A Goldenberg
Blood | VOL. -
Anthony A Sochet, et. al.Anthony A Sochet ... Neil A Goldenberg
03 Feb 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.
Marcos Garcia-Lacarte ... Sergio Roa
Blood | VOL. -
Marcos Garcia-Lacarte, et. al.Marcos Garcia-Lacarte ... Sergio Roa
03 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.